High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

Bibliographic Details
Main Authors: Papaemmanuil, E, Gerstung, M, Malcovati, L, Tauro, S, Gundem, G, Van Loo, P, Pellagatti, A, Groves, M, Cross, N, Gambacorti-Passerini, C, Green, A, Boultwood, J, Vyas, P, Hellstrom-Lindberg, E, Bowen, D, Cazzola, M, Stratton, MR, Campbell, P
Format: Conference item
Published: 2012

Similar Items